{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:13:21Z","timestamp":1791245601566,"version":"4.1.0"},"reference-count":72,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Context.\u2014Patients with plasma cell dyscrasias (myeloma) may exhibit a variety of renal manifestations as a result of damage from circulating light- and heavy-chain immunoglobulin components produced by the neoplastic plasma cells. The renal alterations can occur in any of the renal compartments, and in a significant number of the cases more than one compartment is affected. Research in the laboratory has helped considerably in providing a solid conceptual understanding of how renal damage occurs.<\/jats:p>\n                  <jats:p>Objectives.\u2014To detail advances that have been made in the diagnosis of these conditions and to provide an account of research accomplishments that have solidified diagnostic criteria. The new knowledge that has been acquired serves to provide a solid platform for the future design of new therapeutic interventions aimed at ameliorating or abolishing the progressive renal damage that typically takes place.<\/jats:p>\n                  <jats:p>Data Sources.\u2014Translational efforts have substantially contributed to elucidate mechanistically the molecular events responsible for the renal damage. The spectrum of renal manifestations associated with plasma cell dyscrasias has expanded significantly in the last 10 years. Diagnostic criteria have also been refined. This information has been summarized from work done at several institutions.<\/jats:p>\n                  <jats:p>Conclusions.\u2014A number of significant challenges remain in the diagnosis of these conditions, some of which will be discussed in this article. Dealing with these challenges will require additional translational efforts and close cooperation between basic researchers, clinicians, and pathologists in order to improve the diagnostic tools available to renal pathologists and to acquire a more complete understanding of clinical and pathologic manifestations associated with these conditions.<\/jats:p>","DOI":"10.5858\/133.2.249","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T09:22:55Z","timestamp":1613121775000},"page":"249-267","source":"Crossref","is-referenced-by-count":42,"title":["Renal Lesions Associated With Plasma Cell Dyscrasias: Practical Approach to Diagnosis, New Concepts, and Challenges"],"prefix":"10.5858","volume":"133","author":[{"given":"Guillermo A.","family":"Herrera","sequence":"first","affiliation":[{"name":"From the Pathology Department, Nephrocor Laboratory, Tempe, Ariz"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"key":"2021021102204373400_i1543-2165-133-2-249-b1","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance.","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"2021021102204373400_i1543-2165-133-2-249-b2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4065\/81.5.693","article-title":"Monoclonal gammopathy of undetermined significance, Waldenstrom macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment.","volume":"81","author":"Rajkumar","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"2021021102204373400_i1543-2165-133-2-249-b3","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","article-title":"Monoclonal gammopathy of undetermined significance: natural history in 241 cases.","volume":"64","author":"Kyle","year":"1978","journal-title":"Am J Med"},{"key":"2021021102204373400_i1543-2165-133-2-249-b4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance.","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"2021021102204373400_i1543-2165-133-2-249-b5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1092-9134(00)90042-X","article-title":"Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.","volume":"4","author":"Herrera","year":"2000","journal-title":"Ann Diagn Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b6","first-page":"324","article-title":"Monoclonal immunoglobulin light chain-related renal diseases.","volume":"13","author":"Sanders","year":"1993","journal-title":"Sem Nephrol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.7326\/0003-4819-76-3-112-6-455","article-title":"Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis.","volume":"112","author":"Buxbaum","year":"1990","journal-title":"Ann Int Med"},{"key":"2021021102204373400_i1543-2165-133-2-249-b8","first-page":"527","article-title":"The spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition.","volume":"64","author":"Sanders","year":"1991","journal-title":"Lab Invest"},{"key":"2021021102204373400_i1543-2165-133-2-249-b9","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V1271482","article-title":"Renal monoclonal immunoglobulin deposition disease: the disease spectrum.","volume":"12","author":"Lin","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00125480-200401000-00005","article-title":"Dysproteinemia and the kidney.","volume":"11","author":"Markowitz","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b11","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1681\/ASN.2006020139","article-title":"Multiple myeloma.","volume":"17","author":"Korbet","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/01913129409023211","article-title":"Ultrastructural immunolabeling: a unique diagnostic tool in monoclonal light chain related renal diseases.","volume":"18","author":"Herrera","year":"1994","journal-title":"Ultrastruct Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007950100000","article-title":"The contributions of electron microscopy to the understanding and diagnosis of plasma cell dyscrasia-related renal lesions.","volume":"34","author":"Herrera","year":"2001","journal-title":"Med Elect Microsc"},{"key":"2021021102204373400_i1543-2165-133-2-249-b14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/CVI.13.2.277-280.2006","article-title":"Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophresis.","volume":"13","author":"Jaskowski","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b15","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.4065\/81.12.1575","article-title":"Elimination of need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.","volume":"81","author":"Katzmann","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"2021021102204373400_i1543-2165-133-2-249-b16","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/00000478-200311000-00013","article-title":"Metachronous development of nonamyloidotic lambda light chain deposition disease and IgG heavy chain amyloidosis in the same patient.","volume":"27","author":"Copeland","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.ki.5001545","article-title":"IgG1 lambda light and heavy chain renal amyloidosis.","volume":"70","author":"Nasr","year":"2006","journal-title":"Kidney Int"},{"key":"2021021102204373400_i1543-2165-133-2-249-b18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/ajkd.1998.v32.pm9740176","article-title":"The kidney in plasma cell dyscrasias: Bence-Jones cast nephropathy and light chain deposit disease.","volume":"32","author":"Cohen","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"2021021102204373400_i1543-2165-133-2-249-b19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.ki.5001524","article-title":"Dysproteinemia-related nephropathy associated with crystal-storing histiocytosis.","volume":"70","author":"Stokes","year":"2006","journal-title":"Kidney Int"},{"key":"2021021102204373400_i1543-2165-133-2-249-b20","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00005792-198009000-00005","article-title":"Multiple myeloma: a clinicopathic study of 62 consecutively autopsied cases.","volume":"59","author":"Kapadia","year":"1980","journal-title":"Medicine (Baltimore)"},{"key":"2021021102204373400_i1543-2165-133-2-249-b21","first-page":"986","article-title":"Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.","volume":"114","author":"Ivanyi","year":"1990","journal-title":"Arch Pathol Lab Med"},{"key":"2021021102204373400_i1543-2165-133-2-249-b22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.5858\/2004-128-875-RPSIAA","article-title":"Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasias.","volume":"128","author":"Herrera","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"2021021102204373400_i1543-2165-133-2-249-b23","first-page":"A262","article-title":"Lesions associated with plasma cell dyscrasias in renal biopsies: a 10 year retrospective study [abstract].","volume":"86","author":"Herrera","year":"2006","journal-title":"Lab Invest"},{"key":"2021021102204373400_i1543-2165-133-2-249-b24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1159\/000064299","article-title":"Cast nephropathy in a case of Waldenstrom's macroglobulinemia.","volume":"91","author":"Isaac","year":"2002","journal-title":"Nephron"},{"key":"2021021102204373400_i1543-2165-133-2-249-b25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/ajcp\/92.5.662","article-title":"Macrophage origin of the multinucleated cells of myeloma cast nephropathy.","volume":"92","author":"Alpers","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1172\/JCI119218","article-title":"Localization of a single binding site for immunoglobulin light chains on human Tamm-Horsfall glycoprotein.","volume":"99","author":"Huang","year":"1997","journal-title":"J Clin Invest"},{"key":"2021021102204373400_i1543-2165-133-2-249-b27","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0002-9440(10)64142-9","article-title":"Mapping the binding domain of immunoglobulin light chains for Tamm-Horsfall protein.","volume":"158","author":"Ying","year":"2001","journal-title":"Am J Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b28","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0002-9343(87)90174-4","article-title":"Light chain cast nephropathy and acute renal failure associated with rifampin therapy.","volume":"82","author":"Soffer","year":"1987","journal-title":"Am J Med"},{"key":"2021021102204373400_i1543-2165-133-2-249-b29","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/01.ASN.0000057542.86377.5A","article-title":"Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use.","volume":"14","author":"Smith","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/01913120600689749","article-title":"Ultrastructure of tubular cases.","volume":"30","author":"Uribe-Uribe","year":"2006","journal-title":"Ultrastruct Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b31","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/sj.ki.5002411","article-title":"Intra-tubular amyloidosis.","volume":"72","author":"El-Zoghby","year":"2007","journal-title":"Kidney Int"},{"key":"2021021102204373400_i1543-2165-133-2-249-b32","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.5858\/2007-131-1368-ETPSOI","article-title":"Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy.","volume":"131","author":"Kapur","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"2021021102204373400_i1543-2165-133-2-249-b33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.1987.286","article-title":"Human Bruce Jones protein toxicity in rat proximal tubule epithelium.","volume":"32","author":"Sanders","year":"1987","journal-title":"Kidney Int"},{"key":"2021021102204373400_i1543-2165-133-2-249-b34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1053\/ajkd.2000.17620","article-title":"Cytotoxicity of myeloma, light chains in cultured human kidney proximal tubular cells.","volume":"36","author":"Pote","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"2021021102204373400_i1543-2165-133-2-249-b35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0002-9343(75)90601-4","article-title":"Fanconi syndrome in adults: a manifestation of a latent form of myeloma.","volume":"58","author":"Maldonado","year":"1975","journal-title":"Am J Med"},{"key":"2021021102204373400_i1543-2165-133-2-249-b36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/019131290945727","article-title":"Plasma cell dyscrasia with kappa light chain crystals in proximal tubular cells: a histological, immunofluorescence and ultrastructural study.","volume":"30","author":"Cai","year":"2006","journal-title":"Ultrastruct Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/ajkd.2003.50062","article-title":"A monoclonal V kappa l light chain responsible for incomplete proximal tubulopathy.","volume":"41","author":"Decourt","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2021021102204373400_i1543-2165-133-2-249-b38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ndt\/14.suppl_1.4","article-title":"The molecular basis of plasma cell dyscrasia-related renal diseases.","volume":"14","author":"Ronco","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"2021021102204373400_i1543-2165-133-2-249-b39","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1182\/blood-2005-11-4419","article-title":"Role of the monoclonal {kappa}chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome.","volume":"108","author":"Sirac","year":"2006","journal-title":"Blood"},{"key":"2021021102204373400_i1543-2165-133-2-249-b40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5858\/2006-130-165-LATINA","article-title":"Light-chain-mediated acute tubular interstitial nephritis: a poorly recognized pattern of renal disease in patients with plasma cell dyscrasia.","volume":"130","author":"Gu","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"2021021102204373400_i1543-2165-133-2-249-b41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000167600","article-title":"Morphologic variants of light-chain deposition disease in the kidney.","volume":"8","author":"Venkataseshan","year":"1988","journal-title":"Am J Nephrol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b42","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJM199311043291905","article-title":"Brief report: heavy-chain deposition disease.","volume":"329","author":"Aucouturier","year":"1993","journal-title":"N Engl J Med"},{"key":"2021021102204373400_i1543-2165-133-2-249-b43","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0272-6386(99)70432-4","article-title":"Heavy chain deposition disease: the disease spectrum.","volume":"33","author":"Kambham","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"2021021102204373400_i1543-2165-133-2-249-b44","doi-asserted-by":"crossref","article-title":"An in-vitro model of light chain deposition disease.","author":"Keeling","DOI":"10.1038\/ki.2008.504"},{"key":"2021021102204373400_i1543-2165-133-2-249-b45","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1681\/ASN.V1271558","article-title":"Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level.","volume":"12","author":"Ronco","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0272-6386(96)90315-7","article-title":"Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin heavy chain deposition.","volume":"28","author":"Cheng","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"2021021102204373400_i1543-2165-133-2-249-b47","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0046-8177(94)90007-8","article-title":"Growth factors in monoclonal light chain-related renal diseases.","volume":"25","author":"Herrera","year":"1994","journal-title":"Hum Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b48","first-page":"394","article-title":"Gamma-heavy chain deposition disease showing nodular glomerulosclerosis.","volume":"44","author":"Yasuda","year":"1995","journal-title":"Clin Nephrol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b49","first-page":"485","article-title":"Integrated expression of glomerular extracellular proteins and \u03b21 integrins in monoclonal light chain-related renal diseases.","volume":"10","author":"Turbat-Herrera","year":"1997","journal-title":"Mod Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b50","first-page":"375","article-title":"Pathogenesis of glomerulosclerosis in light chain deposition disease: role for transforming growth factor-\u03b2.","volume":"147","author":"Zhu","year":"1995","journal-title":"Am J Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1053\/hupa.2002.126189","article-title":"Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking.","volume":"33","author":"Markowitz","year":"2002","journal-title":"Hum Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b52","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/modpathol.3800368","article-title":"Expanding the pathologic spectrum of light chain deposition disease: a rare variant with clinical follow-up of 7 years.","volume":"18","author":"Chang","year":"2005","journal-title":"Mod Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000182980","article-title":"Multiple myeloma presenting as dense deposit disease: light chain nephropathy.","volume":"34","author":"Knobler","year":"1983","journal-title":"Nephron"},{"key":"2021021102204373400_i1543-2165-133-2-249-b54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-9343(76)90440-X","article-title":"Manifestations of systemic light chain deposition.","volume":"60","author":"Randall","year":"1976","journal-title":"Am J Med"},{"key":"2021021102204373400_i1543-2165-133-2-249-b55","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.pas.0000213358.18380.d2","article-title":"Pulmonary light chain deposition disease: report of five cases and review of the literature.","volume":"31","author":"Bhargava","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b56","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1523-1755.2005.00571.x","article-title":"Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage.","volume":"68","author":"Keeling","year":"2005","journal-title":"Kidney Int"},{"key":"2021021102204373400_i1543-2165-133-2-249-b57","doi-asserted-by":"crossref","first-page":"850","DOI":"10.5858\/2007-131-850-TBOSAT","article-title":"The burden of \u201csticky\u201d amyloid: typing challenges.","volume":"131","author":"Picken","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"2021021102204373400_i1543-2165-133-2-249-b58","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00000478-200304000-00016","article-title":"Immunoglobulin heavy chain can be amyloidogenic: morphologic characterization, including immunoelectron microscopy.","volume":"27","author":"Mai","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b59","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1093\/ndt\/gfh503","article-title":"AL-amyloidosis is underdiagnosed in renal biopsies.","volume":"19","author":"Novak","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"2021021102204373400_i1543-2165-133-2-249-b60","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/01913120390231555","article-title":"Organized deposits and look-alikes.","volume":"27","author":"Howell","year":"2003","journal-title":"Ultrastruct Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b61","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/ki.1992.433","article-title":"Clinical and pathologic features of fibrillary glomerulonephritis.","volume":"42","author":"Iskandar","year":"1992","journal-title":"Kidney Int"},{"key":"2021021102204373400_i1543-2165-133-2-249-b62","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1523-1755.2003.00853.x","article-title":"Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features.","volume":"63","author":"Rosenstock","year":"2003","journal-title":"Kidney Int"},{"key":"2021021102204373400_i1543-2165-133-2-249-b63","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0272-6386(12)70290-1","article-title":"The fibrillary glomerulopathies.","volume":"23","author":"Korbet","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"2021021102204373400_i1543-2165-133-2-249-b64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/01913120490430436","article-title":"Atypical amyloidosis: diagnostic challenges and the role of immunoelectron microscopy in diagnosis.","volume":"28","author":"Veeramachaneni","year":"2004","journal-title":"Ultrastruct Pathol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b65","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1440-1827.2007.02116.x","article-title":"The role of translational research advancing the understanding of the pathogenesis of light chain (LC)-mediated glomerulopathies.","volume":"57","author":"Teng","year":"2007","journal-title":"Pathol Int"},{"key":"2021021102204373400_i1543-2165-133-2-249-b66","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/jsbi.2000.4248","article-title":"Review: immunoglobulin light chain amyloidosis\u2014the archetype of structural and pathogenic variability.","volume":"130","author":"Bellotti","year":"2000","journal-title":"J Struct Biol"},{"key":"2021021102204373400_i1543-2165-133-2-249-b67","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/13506120009146437","article-title":"Glycosylation of immunoglobulin light chains associated with amyloidosis.","volume":"7","author":"Omtvedt","year":"2000","journal-title":"Amyloid"},{"key":"2021021102204373400_i1543-2165-133-2-249-b68","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ki.1994.355","article-title":"Monoclonal immunoglobulin deposition disease (Randall type): relationship with structural abnormalities of immunogloblin chains.","volume":"46","author":"Preud'homme","year":"1994","journal-title":"Kidney Int"},{"key":"2021021102204373400_i1543-2165-133-2-249-b69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20436.x","article-title":"Structure of abnormal heavy chains in human heavy chain deposition disease.","volume":"229","author":"Khamlichi","year":"1995","journal-title":"Eur J Biochem"},{"key":"2021021102204373400_i1543-2165-133-2-249-b70","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1182\/blood.V98.3.714","article-title":"The tropism of organ involvement in primary systemic amyloidosis: contributions of IgVL germline gene use and clonal plasma cell burden.","volume":"98","author":"Comenzo","year":"2001","journal-title":"Blood"},{"key":"2021021102204373400_i1543-2165-133-2-249-b71","first-page":"269","article-title":"Protein and host factors implicated in the pathogenesis of light chain amyloidosis (AL amyloidosis).","volume":"2","author":"Solomon","year":"1995","journal-title":"Int J Exp Clin Invest"},{"key":"2021021102204373400_i1543-2165-133-2-249-b72","doi-asserted-by":"crossref","first-page":"835","DOI":"10.7326\/0003-4819-143-11-200512060-00013","article-title":"Managing myeloma kidney.","volume":"143","author":"Gertz","year":"2005","journal-title":"Ann Intern Med"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/133\/2\/249\/2767128\/1543-2165-133_2_249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/133\/2\/249\/2767128\/1543-2165-133_2_249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:37:00Z","timestamp":1764790620000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/133\/2\/article-p249.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,1]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2,1]]}},"URL":"https:\/\/doi.org\/10.5858\/133.2.249","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2,1]]}}}